The Valley Desk

ArticleSchizophrenia bulletinPublished

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

29 of 247 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Temple University, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Schizophrenia bulletin
Published
Subject terms
Humans; Prospective Studies; Psychotic Disorders; Schizophrenia; Research Design; International Cooperation; Adolescent; Adult; Female; Male; Young Adult; Prodromal Symptoms
PubMed ID
38451304
PubMed Central ID
PMC11059785
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal